← Back to Vivo Capital profile
Vivo Capital related stories
All articles and analysis
PE Week Wire: Tuesday, September 30, 2008Tuesday Talkback
- Exit watch, week of Sept. 29, 2008
News about venture-backed Prestwick Pharma and other companies that were acquired in the last week
- VCs Take Loss on Prestwick Pharma Sale
Biovail Corp. (NYSE: BVF) has acquired Prestwick Pharmaceuticals Inc., a Washington, D.C.-based drug company focused on CNS disorders, for $100 million in cash. Prestwick had raised around $120 million in total VC funding since 2002, from firms like Atlas Venture, Pequot Ventures, Scale Venture Partners, Sofinnova Ventures, Vivo Ventures and Warburg Pincus.
- PE Week Wire: Thursday, September 18, 2008
Random Ramblings
- PE Week Wire: Thursday, September 18, 2008
Random Ramblings
- Week in deals, Sept. 15, 2008
News and notes for tech companies and other businesses that raised financing in North America in the past week
- PE Week Wire: Thursday, September 4, 2008
Random Ramblings
- PE Week Wire: Thursday, September 4, 2008
Random Ramblings
- PE Week Wire: Wednesday, September 3, 2008
Random Ramblings